Actinogen Medical Expects Results From XanaCIDD Phase 2a Clinical Trial in August; Shares Down 6%

MT NewswiresJul 2 00:48 ET

Actinogen's Xanamem Could Slow Alzheimer's Progress, New Biomarker Trial Reveals

Small CapsJun 25 22:33 ET

Stocks of the Hour: Actinogen Medical, De Grey Mining, Cooper Metals

sharecafeJun 25 21:50 ET

Actinogen Medical Completes AU$3.9 Million Non-Renounceable Entitlement Offer

MT NewswiresMay 29 20:12 ET

Actinogen Medical Opens AU$3.9 Million Entitlement Offer; Shares Down 7%

MT NewswiresMay 15 00:52 ET

Actinogen Medical Lodges Prospectus for Nearly AU$4 Million Entitlement Offer

MT NewswiresMay 7 00:52 ET